Autoimmune diseases are one of the common diseases that can be dangerous if not treated promptly. The disease includes more than 180 different types, commonly in young people, women are at higher risk of the disease than men.

Autoimmune disease is a fairly common disease that exists in more than 180 different forms. To diagnose autoimmune disease, the patient needs to do some specific tests.

Autoimmune diseases account for about 3-5% of the population due to the formation of autoimmune antibodies against organ tissue components including cell nucleus, cytoplasm, cell membrane... Therefore, testing to find the circulation of autoimmune antibodies in immune diseases is very necessary, in which the soluble antigen antibody test is often done after a positive ANA test to detect autoimmune diseases.

The ANA test is a test that detects antinuclear antibodies (ANA) in your blood. It is an essential tool in diagnosing autoimmune diseases. A positive ANA test may indicate that your immune system is mistakenly attacking your own tissues, in other words, an autoimmune reaction.

Antinuclear antibodies and anti-double-stranded antibodies are autoantibodies that appear in autoimmune diseases. Accordingly, testing to detect and quantify these antibodies is aimed at diagnosing confusing dysfunctions of the immune system when clinical signs are suggestive.

Identify the agent causing the allergy in the patient, from which the patient can be advised on appropriate methods to avoid future allergies. In patients who are sensitive to allergens, specific IgE can be detected in the specimen, but the patient has no clinical symptoms.

Antinuclear antibodies (ANA) are antibodies that attack the nucleus of cells. The ANA test, along with clinical symptoms, a physical exam, and other tests, helps doctors diagnose autoimmune diseases, including lupus.

The 23 antinuclear antibody test plays a very important role in determining the type of autoantibody, helping doctors accurately diagnose autoimmune diseases, especially rheumatic diseases.

ANA-Hep2 IIFT test is an ANA screening test using indirect immunofluorescence technology (Indirect ImmunoFluorescense Technology) using Hep2 cells (Human Epithelial type 2) as substrate.

The ANA test detects antinuclear antibodies in the blood. The normal immune system produces antibodies to help the body fight infections. In contrast, antinuclear antibodies often attack the body’s own tissues – specifically targeting the nucleus of individual cells – as part of an autoimmune response, in autoimmune diseases such as lupus, rheumatoid arthritis or scleroderma.